Swift Health Systems Raises $45 Million in Series C Funding

IRVINE, CA., October 8, 2019  – Swift Health Systems, Inc., makers of INBRACE®, today announced the company has raised $45MM in series C funding to help bolster commercialization of INBRACE. Financing was co-led by Vivo Capital, Novo Holdings and venBio Partners and brings the total capital raised by the company to more than $70MM. Series C funds will be directed at broadening commercial availability of the innovative INBRACE solution through expanded orthodontist onboarding and training, increased sales and marketing resources and consumer demand generation programs in support of existing and new INBRACE providers.The orthodontic industry is experiencing a huge increase in do-it-yourself (DIY) aligner therapy, which is raising concerns among dental professionals over potential health risks from unsupervised treatment. INBRACE addresses both consumer and orthodontist needs in this evolving market, as a discrete, aesthetic and convenient solution that delivers the health benefits of light-force tooth movement.“INBRACE is a real game-changer, and this latest funding will help us ensure that every INBRACE provider can finally give their patients what they’ve always wanted – a truly invisible journey to a great new smile that is convenient and shows immediate results,” said Dr. John Pham, CEO an d co-founder of Swift Health Systems. “Even with DIY orthodontic therapy on the rise, most consumers appreciate the benefits of supervised healthcare from a license...
Source: Dental Technology Blog - Category: Dentistry Source Type: news